Literature DB >> 23137658

Platelet-derived growth factors and their receptors: structural and functional perspectives.

Po-Han Chen1, Xiaoyan Chen, Xiaolin He.   

Abstract

The four types of platelet-derived growth factors (PDGFs) and the two types of PDGF receptors (PDGFRs, which belong to class III receptor tyrosine kinases) have important functions in the development of connective tissue cells. Recent structural studies have revealed novel mechanisms of PDGFs in propeptide loading and receptor recognition/activation. The detailed structural understanding of PDGF-PDGFR signaling has provided a template that can aid therapeutic intervention to counteract the aberrant signaling of this normally silent pathway, especially in proliferative diseases such as cancer. This review summarizes the advances in the PDGF system with a focus on relating the structural and functional understandings, and discusses the basic aspects of PDGFs and PDGFRs, the mechanisms of activation, and the insights into the therapeutic antagonism of PDGFRs. This article is part of a Special Issue entitled: Emerging recognition and activation mechanisms of receptor tyrosine kinases.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Growth factor; Propeptide recognition; Receptor activation; Receptor tyrosine kinase; Signal transduction

Mesh:

Substances:

Year:  2012        PMID: 23137658      PMCID: PMC3612563          DOI: 10.1016/j.bbapap.2012.10.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  84 in total

Review 1.  Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family.

Authors:  Laila J Reigstad; Jan E Varhaug; Johan R Lillehaug
Journal:  FEBS J       Date:  2005-11       Impact factor: 5.542

2.  Structural basis for stem cell factor-KIT signaling and activation of class III receptor tyrosine kinases.

Authors:  Heli Liu; Xiaoyan Chen; Pamela J Focia; Xiaolin He
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

3.  Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies.

Authors:  Hideo Akiyama; Shu Kachi; Raquel Lima E Silva; Naoyasu Umeda; Sean F Hackett; Dilara McCauley; Thomas McCauley; Anna Zoltoski; David M Epstein; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2006-05       Impact factor: 6.384

Review 4.  The biology of vascular endothelial growth factors.

Authors:  Tuomas Tammela; Berndt Enholm; Kari Alitalo; Karri Paavonen
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

5.  Structure of a VEGF-VEGF receptor complex determined by electron microscopy.

Authors:  Claudia Ruch; Georgios Skiniotis; Michel O Steinmetz; Thomas Walz; Kurt Ballmer-Hofer
Journal:  Nat Struct Mol Biol       Date:  2007-02-11       Impact factor: 15.369

6.  The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain.

Authors:  Mark Walter; Isabelle S Lucet; Onisha Patel; Sophie E Broughton; Rebecca Bamert; Neal K Williams; Emmanuelle Fantino; Andrew F Wilks; Jamie Rossjohn
Journal:  J Mol Biol       Date:  2007-01-20       Impact factor: 5.469

7.  Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.

Authors:  Carolyn V Ustach; Hyeong-Reh Choi Kim
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

8.  Alix facilitates the interaction between c-Cbl and platelet-derived growth factor beta-receptor and thereby modulates receptor down-regulation.

Authors:  Johan Lennartsson; Piotr Wardega; Ulla Engström; Ulf Hellman; Carl-Henrik Heldin
Journal:  J Biol Chem       Date:  2006-11-02       Impact factor: 5.157

9.  Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.

Authors:  Alexandra Abramsson; Sindhulakshmi Kurup; Marta Busse; Shuhei Yamada; Per Lindblom; Edith Schallmeiner; Denise Stenzel; Dominique Sauvaget; Johan Ledin; Maria Ringvall; Ulf Landegren; Lena Kjellén; Göran Bondjers; Jin-ping Li; Ulf Lindahl; Dorothe Spillmann; Christer Betsholtz; Holger Gerhardt
Journal:  Genes Dev       Date:  2007-02-01       Impact factor: 11.361

10.  Origin and molecular evolution of receptor tyrosine kinases with immunoglobulin-like domains.

Authors:  Julien Grassot; Manolo Gouy; Guy Perrière; Guy Mouchiroud
Journal:  Mol Biol Evol       Date:  2006-03-21       Impact factor: 16.240

View more
  69 in total

Review 1.  PDGF/PDGFR axis in the neural systems.

Authors:  Susmita Sil; Palsamy Periyasamy; Annadurai Thangaraj; Ernest T Chivero; Shilpa Buch
Journal:  Mol Aspects Med       Date:  2018-02-06

2.  A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome.

Authors:  Cecilie Bredrup; Tomasz Stokowy; Julie McGaughran; Samuel Lee; Dipak Sapkota; Ileana Cristea; Linda Xu; Kåre Steinar Tveit; Gunnar Høvding; Vidar Martin Steen; Eyvind Rødahl; Ove Bruland; Gunnar Houge
Journal:  Eur J Hum Genet       Date:  2018-12-20       Impact factor: 4.246

3.  Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression.

Authors:  Yusuke Higashi; Srinivas Mummidi; Sergiy Sukhanov; Tadashi Yoshida; Makoto Noda; Patrice Delafontaine; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2019-02-01       Impact factor: 4.315

4.  The N Terminus of Human Cytomegalovirus Glycoprotein O Is Important for Binding to the Cellular Receptor PDGFRα.

Authors:  Cora Stegmann; Franziska Rothemund; Kerstin Laib Sampaio; Barbara Adler; Christian Sinzger
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

5.  MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.

Authors:  Yanzhi Yang; Samantha Dodbele; Thomas Park; Rainer Glass; Krishna Bhat; Erik P Sulman; Ying Zhang; Roger Abounader
Journal:  J Neurooncol       Date:  2019-09-03       Impact factor: 4.130

Review 6.  The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.

Authors:  Wen-Hai Shao; Philip L Cohen
Journal:  Expert Rev Clin Immunol       Date:  2014-03-29       Impact factor: 4.473

Review 7.  Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease.

Authors:  Helena M Kok; Lucas L Falke; Roel Goldschmeding; Tri Q Nguyen
Journal:  Nat Rev Nephrol       Date:  2014-10-14       Impact factor: 28.314

Review 8.  More than the sum of the parts: Toward full-length receptor tyrosine kinase structures.

Authors:  Devan Diwanji; Tarjani Thaker; Natalia Jura
Journal:  IUBMB Life       Date:  2019-05-02       Impact factor: 3.885

9.  MicroRNA-9 regulates cardiac fibrosis by targeting PDGFR-β in rats.

Authors:  Lei Wang; LiKun Ma; Hai Fan; Zhe Yang; LongWei Li; HanZhang Wang
Journal:  J Physiol Biochem       Date:  2016-02-19       Impact factor: 4.158

10.  Harnessing biomolecules for bioinspired dental biomaterials.

Authors:  Nicholas G Fischer; Eliseu A Münchow; Candan Tamerler; Marco C Bottino; Conrado Aparicio
Journal:  J Mater Chem B       Date:  2020-08-04       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.